{"title":"Clinically Determined Asterixis Is Markedly Increased in Patients Taking Clozapine.","authors":"Joseph H Friedman","doi":"10.1097/WNF.0000000000000539","DOIUrl":null,"url":null,"abstract":"To the Editor: A sterixis, also known as negative myoclonus, is caused by a 50to 200-ms silence in electrical impulses to a tonically contracting muscle. It was originally described in the hands as a “flapping” tremor, but it may be seen in other parts of the body. It commonly appears in toxic and metabolic encephalopathies, but may be present with medications at non-toxic doses, seizures, central nervous system infections, and other disorders. It may be co-existent with myoclonus. Possible asterixis has been rarely reported in patients treated with clozapine (Cloz), but most articles reported poorly described episodes lasting under 2 minutes, of “knee buckling,” “dropping things,” and “cataplexy.” This study was undertaken to determine how often asterixis was present in the hands and arms in patients taking Cloz, even at the extremely low doses (usually 6.25–50 mg) used in people with Parkinson disease (PD).","PeriodicalId":10449,"journal":{"name":"Clinical Neuropharmacology","volume":"46 2","pages":"87"},"PeriodicalIF":0.8000,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Neuropharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/WNF.0000000000000539","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
To the Editor: A sterixis, also known as negative myoclonus, is caused by a 50to 200-ms silence in electrical impulses to a tonically contracting muscle. It was originally described in the hands as a “flapping” tremor, but it may be seen in other parts of the body. It commonly appears in toxic and metabolic encephalopathies, but may be present with medications at non-toxic doses, seizures, central nervous system infections, and other disorders. It may be co-existent with myoclonus. Possible asterixis has been rarely reported in patients treated with clozapine (Cloz), but most articles reported poorly described episodes lasting under 2 minutes, of “knee buckling,” “dropping things,” and “cataplexy.” This study was undertaken to determine how often asterixis was present in the hands and arms in patients taking Cloz, even at the extremely low doses (usually 6.25–50 mg) used in people with Parkinson disease (PD).
期刊介绍:
Clinical Neuropharmacology is a peer-reviewed journal devoted to the pharmacology of the nervous system in its broadest sense. Coverage ranges from such basic aspects as mechanisms of action, structure-activity relationships, and drug metabolism and pharmacokinetics, to practical clinical problems such as drug interactions, drug toxicity, and therapy for specific syndromes and symptoms. The journal publishes original articles and brief reports, invited and submitted reviews, and letters to the editor. A regular feature is the Patient Management Series: in-depth case presentations with clinical questions and answers.